Together, beyond animal health
COMPOSITION
VECTORMUNE® HVT NDV & SB1 contains a genetically engineered Marek Disease virus of serotype 3 (turkey Herpesvirus or HVT) expressing a key protective antigen of Newcastle Disease virus. This bivalent Marek Disease vaccine containing serotypes 2 and 3 is presented in a frozen cell-associated form.
INDICATIONS
VECTORMUNE® HVT NDV & SB1 is recommended for use in healthy one-dayold chicks or in 18 to 19-day-old embryonated chicken eggs as an aid in the prevention of Newcastle Disease and very virulent Marek Disease.
ADMINISTRATION AND DOSAGE
Prior to use, the vaccine must be thawed and diluted appropriately with the vaccine
diluent as started in the package insert. Immediately use the vaccine and
mix occasionally to ensure uniform suspension of cells.
For in ovo administration, embryos are inoculated with one full dose of vaccine
(in 0,05 or 0,1 ml diluent / dose).
For day-old vaccination, one-day-old chicks are subcutaneously vaccinated
with one full dose of vaccine ( in 0,2 ml of diluent / dose) in the back of the
neck.
STORAGE
Store this vaccine in liquid nitrogen.
PACKAGED
1,000; 2,000 and 4,000 dose ampules